Gardner JM - Search Results

1

Gardner JM, Nelson MM, Heffernan MP. Gardner JM, et al. Arch Dermatol. 2005 Jun;141(6):794-5. doi: 10.1001/archderm.141.6.794. Arch Dermatol. 2005. PMID: 15967939 No abstract available.

2

Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Goldstein S, Kim EJ, Vittorio CC, Rook AH. Gardner JM, et al. Arch Dermatol. 2009 Sep;145(9):985-8. doi: 10.1001/archdermatol.2009.229. Arch Dermatol. 2009. PMID: 19770436 No abstract available.

3

High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.

Raphael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Samimi SS, Gelfand JM, Rook AH. Raphael BA, et al. Among authors: gardner jm. Arch Dermatol. 2011 Dec;147(12):1410-5. doi: 10.1001/archdermatol.2011.232. Epub 2011 Aug 15. Arch Dermatol. 2011. PMID: 21844430

4

CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.

Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. Introcaso CE, et al. Among authors: gardner j. Arch Dermatol. 2008 Aug;144(8):1027-9. doi: 10.1001/archderm.144.8.1027. Arch Dermatol. 2008. PMID: 18711076

5

Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-cell lymphoma.

Samimi S, Morrissey K, Anshelevich S, Evans K, Gardner J, Musiek A, Vittorio C, Rook A, Kim E. Samimi S, et al. J Am Acad Dermatol. 2013 Jan;68(1):e5-6. doi: 10.1016/j.jaad.2011.06.043. J Am Acad Dermatol. 2013. PMID: 23244387 No abstract available.

6

Update on treatment of cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ. Gardner JM, et al. Curr Opin Oncol. 2009 Mar;21(2):131-7. doi: 10.1097/CCO.0b013e3283253190. Curr Opin Oncol. 2009. PMID: 19532014 Review.

7

A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome.

Gardner JM, Introcaso CE, Nasta SD, Kim EJ, Vittorio CC, Rook AH. Gardner JM, et al. J Am Acad Dermatol. 2009 Jul;61(1):112-6. doi: 10.1016/j.jaad.2008.11.889. J Am Acad Dermatol. 2009. PMID: 19539845

8

Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy.

Klein RS, Dunlop JD, Samimi SS, Morrissey KA, Evans KG, Gardner JM, Introcaso CE, Vittorio CC, Rook AH, Micaily B, Kim EJ. Klein RS, et al. Among authors: gardner jm. J Am Acad Dermatol. 2013 Jun;68(6):972-7. doi: 10.1016/j.jaad.2012.09.056. Epub 2013 Feb 12. J Am Acad Dermatol. 2013. PMID: 23415461

9

Macrophage-specific hypoxia inducible factor 2α expression promotes cardiac allograft tolerance.

Arvedson MP, Gardner JM. Arvedson MP, et al. Among authors: gardner jm. Am J Transplant. 2024 Dec 21:S1600-6135(24)00762-7. doi: 10.1016/j.ajt.2024.12.010. Online ahead of print. Am J Transplant. 2024. PMID: 39716691 No abstract available.

10

Implantation of autologous induced pluripotent stem cell-derived islets provides long-term insulin independence in a patient with type 1 diabetes.

Chu SN, Stock PG, Gardner JM. Chu SN, et al. Among authors: gardner jm. Am J Transplant. 2024 Dec;24(12):2144-2145. doi: 10.1016/j.ajt.2024.11.005. Am J Transplant. 2024. PMID: 39581675 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters